# FDA Inspection 1242236 - Stembanc Holdings Inc - June 06, 2024

Source: https://www.keypedia.com/records/fda_inspections/stembanc-holdings-inc/642d87c3-984e-4a79-966b-9fbb6340d0ba
Source feed: FDA_Inspections

> FDA Inspection 1242236 for Stembanc Holdings Inc on June 06, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242236
- Company Name: Stembanc Holdings Inc
- Inspection Date: 2024-06-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1154700 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-holdings-inc/e4d99e70-7e15-4f78-b8fa-b958165e98dd)
- [FDA Inspection 1154700 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-holdings-inc/8f58b15a-395a-46f7-848e-5d0dff651c7b)
- [FDA Inspection 1154700 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-holdings-inc/c93b280e-bb20-4c6f-93c9-13c0a177534a)

Company: https://www.keypedia.com/companies/stembanc-holdings-inc/16fd18c0-ee30-41ee-bff4-8d198ab736cf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d